Antimicrobial effect of clindamycin in combination with aztreonam or aminoglycosides against Klebsiella spp.
The antimicrobial effect of clindamycin combined with aztreonam or an aminoglycoside (gentamicin, tobramycin or amikacin) was studied against 84 strains of Klebsiella pneumoniae and 18 strains of K. oxytoca with an agar dilution technique. Clindamycin concentrations of 1-20 mg/l and an inoculum of 10(4) cuf/spot were used. Anaerobic incubation of agar plates was associated with an increase in the MIC of aminoglycosides and no change or a decrease in the MIC of aztreonam. Lower concentrations of clindamycin (1-2 mg/l) were associated with a decrease in the MIC of aztreonam for 18% and an increase in the MIC of aminoglycosides for between 7% and 44% of the strains, depending upon the precise concentration used. However, higher concentrations of clindamycin (10-20 mg/l) were associated with a decrease in the MIC of aztreonam for between 36 and 87% and an increase in the MIC of aminoglycosides for between 13 and 64% of the isolates. These observations could be important when treatment plans for mixed aerobic/anaerobic infections including mixed Klebsiella spp. are considered.
Baltch
A L
AL
Department of Medicine, Veterans Affairs Medical Center, Albany, NY.
Smith
R P
RP
Hammer
M C
MC
Conroy
J V
JV
Michelsen
P B
PB
D000617:Aminoglycosides / Q000494:pharmacology*; D001398:Aztreonam / Q000494:pharmacology*; D002981:Clindamycin / Q000494:pharmacology*; D004359:Drug Therapy, Combination / Q000494:pharmacology; D007709:Klebsiella / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D013045:Species Specificity
D000617:Aminoglycosides; D002981:Clindamycin; D001398:Aztreonam